Novel methods for determining the anabolic activity of a compound in muscle using microarrays to compare the in vivo changes of the genomic profile of mammalian muscle induced by a tested compound versus the corresponding changes induced by a known anabolic steroid. For example, in vivo changes of the genomic profile in the mouse induced by a tested compound may be compared to the genomic profile changes induced by the androgenic and anabolic steroid dihydrotestosterone (DHT).

 
Web www.patentalert.com

< Methods for screening polypeptides

< Use

> Benzene, pyridine, and pyridazine derivatives

> Regeneration method for treating heart diseases and vascular system diseases using medicament

~ 00243